Metabolic therapy in the comprehensive treatment of patients with comorbidity of chronic pancreatitis and stable coronary artery disease
Journal Title: Гастроентерологія - Year 2017, Vol 51, Issue 1
Abstract
Metabolic therapy is one of the few ways to restore normal functions of all the vital organs and systems. The goal of the research was to explore the effectiveness of a course of treatment using metabolic drug Vazonat (meldonium dihydrate) to correct prooxidant-antioxidant and trophological disorders in patients with comorbid course of chronic pancreatitis (CP) and stable coronary artery disease (SCAD). The study included 90 patients with CP in combination with SCAD, who were divided into two groups (depending on the treatment program): I group (45 patients) received conventional treatment (CT); group II (45 patients) in addition to CT received Vazonat as follows: 5 ml intravenous bolus injection 1 time a day for 10 days followed by administration of 1 capsule (250 mg), 2 times per day for one month. It has been shown that the addition of Vazonat to the treatment of patients with comorbidity of CP and SCAD is more conducive to improving the performance and trophological prooxidant-antioxidant status than the standard basic therapy.
Authors and Affiliations
L. S. Babinets, N. A. Melnyk
Keywords
Related Articles
- EP ID EP212795
- DOI 10.22141/2308-2097.51.1.2017.97867
- Views 98
- Downloads 0
Levels of Type IIA Phospholipase A2 and Type IV Collagen in Patients with Chronic Alcoholic Pancreatitis Associated with Liver Cirrhosis Class A, B by Child-Pugh
In 49 patients, of whom 20 were diagnosed with combined lesions of the pancreas (chronic pancreatitis in the acute stage) and liver (cirrhosis class A, B by Child-Pugh) of alcoholic origin, 12 — with exacerbation of chro...
The role of biologically active substances in gastroesophageal reflux disease in patients with type 2 diabetes mellitus
Background. The factors influencing the progression and clinical manifestations of gastroesophageal reflux disease (GERD) in patients with type 2 diabetes mellitus (DM) have not been sufficiently studied so far. To inve...
Diagnostic Value of Serum Markers of Liver Fibrosis in Patients with HCV-Infection
In the paper we consider the diagnostic possibilities of the use of serum markers of liver fibrosis in patients with chronic HCV-infection. The definition of special tests (AAR, APRI, Forns’ score, FibroIndex, FIB-4, MDA...
Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease
Background. Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of diseases associated with insulin resistance and metabolic disorders, such as obesity, type 2 diabetes mellitus and dyslipidemia. NAFLD includes...
Idiopathic non-cirrhotic portal hypertension and its causes
Idiopathic non-cirrhotic portal hypertension is poorly diagnosed disease of unclear etiology. The disease is slowly progressive and benign, its outcome is more optimistic than in the treatment of portal hypertension comp...